Episode
Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma
- Podcast
- Neuro-Oncology: The Podcast
- Published
- Mar 2, 2026
- Duration seconds
- 1247
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology in January 2026.